⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24138727 | 0.76 | — | — | |
| SCHEMBL24139826 | 0.76 | — | — | |
| SCHEMBL24730372 | 0.73 | — | — | |
| SCHEMBL13713110 | 0.72 | — | — | |
| SCHEMBL31251066 | 0.72 | — | — | |
| SCHEMBL23938122 | 0.72 | — | — | |
| SCHEMBL23938366 | 0.72 | — | — | |
| SCHEMBL24730687 | 0.70 | — | — | |
| SCHEMBL21440590 | 0.70 | — | — | |
| SCHEMBL22249014 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524966-B1 | Carboxamides as ubiquitin-specific protease inhibitors | VALO HEALTH, INC. (US) | 2022-12-13 | — | — | US | disclosed |